URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Sharon Elad

Concepts (398)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Hematopoietic Stem Cell Transplantation
25
1997
131
6.860
Why?
Graft vs Host Disease
24
1997
90
6.270
Why?
Mouth Diseases
12
1999
46
6.200
Why?
Diphosphonates
11
2006
43
5.260
Why?
Osteonecrosis
11
2006
24
4.510
Why?
Dental Care for Chronically Ill
12
1997
17
4.320
Why?
Jaw Diseases
9
2006
15
4.130
Why?
Mouth Mucosa
14
1997
43
3.510
Why?
Bone Density Conservation Agents
7
2007
51
3.430
Why?
Immunosuppressive Agents
10
1997
200
2.500
Why?
Antibiotic Prophylaxis
5
2007
34
2.320
Why?
Stomatitis
6
1997
16
2.100
Why?
Budesonide
3
2003
13
1.880
Why?
Jaw
3
2006
12
1.850
Why?
Mouthwashes
6
1999
30
1.820
Why?
Mouth Neoplasms
5
2007
34
1.750
Why?
Middle Aged
40
1996
9837
1.630
Why?
Humans
83
1993
36274
1.600
Why?
Dental Care
6
2002
47
1.460
Why?
Endocarditis, Bacterial
3
2007
32
1.420
Why?
Practice Guidelines as Topic
8
2006
302
1.360
Why?
Mucositis
4
2006
13
1.250
Why?
Transplantation Conditioning
7
2003
33
1.250
Why?
Male
46
1996
19675
1.200
Why?
Osteomyelitis
2
2006
42
1.170
Why?
American Heart Association
3
2007
24
1.090
Why?
Female
43
1996
19838
1.080
Why?
Pilot Projects
10
1997
442
1.060
Why?
Carcinoma, Squamous Cell
4
2007
236
1.000
Why?
Chronic Disease
11
1997
522
1.000
Why?
Adult
35
1993
11351
0.970
Why?
Anesthetics, Local
3
1999
80
0.950
Why?
Phototherapy
2
2008
17
0.920
Why?
Emergencies
6
2002
81
0.900
Why?
Oral Surgical Procedures
3
2008
9
0.880
Why?
Treatment Outcome
17
1996
2615
0.880
Why?
Head and Neck Neoplasms
3
2007
83
0.860
Why?
Administration, Topical
8
1997
89
0.860
Why?
Antineoplastic Agents, Alkylating
2
2005
42
0.850
Why?
Paraneoplastic Syndromes
3
2007
12
0.830
Why?
Lymphoma, Non-Hodgkin
2
2009
113
0.820
Why?
Antimicrobial Cationic Peptides
1
2011
13
0.810
Why?
Aged
22
2003
7269
0.810
Why?
Anticoagulants
3
1996
135
0.800
Why?
Anti-Infective Agents
2
2006
75
0.790
Why?
Platelet Aggregation Inhibitors
2
2008
61
0.790
Why?
Endocarditis
1
2011
11
0.780
Why?
Tacrolimus
3
2003
66
0.780
Why?
Stroke
3
2004
134
0.770
Why?
Drug Discovery
1
2011
10
0.760
Why?
Calcineurin
1
2010
23
0.750
Why?
Cyclophosphamide
2
2006
174
0.750
Why?
Toothache
1
2010
9
0.740
Why?
Anesthesia, Dental
2
2002
14
0.740
Why?
Osteoporosis
2
2007
85
0.740
Why?
Neurotoxicity Syndromes
1
2010
14
0.730
Why?
Immunocompromised Host
2
2007
83
0.730
Why?
Immunoglobulin Light Chains
1
2010
19
0.730
Why?
Facial Pain
2
2007
47
0.720
Why?
Anti-Inflammatory Agents
4
2003
110
0.720
Why?
Multiple Myeloma
2
2006
76
0.720
Why?
Amyloidosis
1
2010
28
0.720
Why?
Immunologic Factors
1
2011
66
0.720
Why?
Amyloid
1
2010
20
0.720
Why?
Heparin, Low-Molecular-Weight
2
1996
16
0.720
Why?
Bone Marrow Transplantation
7
1996
197
0.720
Why?
Herpesviridae Infections
1
2010
71
0.710
Why?
Blood Pressure
3
2002
467
0.710
Why?
Oral Medicine
1
2009
2
0.710
Why?
Neoplasm Recurrence, Local
2
1997
288
0.710
Why?
Stem Cell Transplantation
2
2005
110
0.700
Why?
Patient Acceptance of Health Care
1
2011
110
0.690
Why?
Clinical Governance
1
2009
1
0.690
Why?
Vasoconstrictor Agents
2
2002
29
0.660
Why?
Opportunistic Infections
1
2008
20
0.650
Why?
Pemphigus
1
2008
8
0.650
Why?
Antineoplastic Combined Chemotherapy Protocols
4
1997
429
0.640
Why?
Antiviral Agents
1
2010
175
0.640
Why?
Root Planing
1
2008
13
0.640
Why?
Neoplasms
4
2003
739
0.640
Why?
Gingival Hemorrhage
1
2008
35
0.630
Why?
Diabetes Mellitus, Type 2
3
2006
224
0.630
Why?
Shock
1
2008
21
0.630
Why?
Gingival Diseases
1
2008
9
0.630
Why?
Leukoplakia, Oral
1
2007
1
0.630
Why?
Pain
2
2003
382
0.620
Why?
Periodontitis
1
2008
61
0.620
Why?
Lymphoproliferative Disorders
1
2008
30
0.610
Why?
Dental Implantation, Endosseous
1
2008
40
0.610
Why?
Precancerous Conditions
1
2007
38
0.610
Why?
Diabetes Complications
1
2008
66
0.600
Why?
Periodontal Diseases
2
2007
73
0.600
Why?
Double-Blind Method
5
2006
992
0.600
Why?
Antineoplastic Agents
3
2006
619
0.590
Why?
Myocardial Ischemia
1
2008
118
0.590
Why?
Xerostomia
4
2006
42
0.580
Why?
Hematologic Diseases
1
2007
39
0.580
Why?
Loratadine
1
2006
2
0.570
Why?
Terfenadine
1
2006
3
0.570
Why?
Saliva
2
2006
215
0.570
Why?
Rhinitis
1
2006
7
0.570
Why?
Candidiasis, Oral
1
2006
24
0.560
Why?
Chlorhexidine
1
2006
27
0.560
Why?
Amphotericin B
1
2006
25
0.550
Why?
Histamine
1
2006
20
0.550
Why?
Decision Support Techniques
1
2007
74
0.550
Why?
Severity of Illness Index
2
2009
922
0.550
Why?
Gels
1
2006
48
0.550
Why?
Salivary Glands
1
2006
65
0.540
Why?
Risk Factors
9
1993
2345
0.540
Why?
Heart Rate
1
2008
461
0.530
Why?
Young Adult
7
2009
1059
0.530
Why?
Antifungal Agents
1
2006
62
0.530
Why?
Prospective Studies
7
2006
1689
0.520
Why?
Research Design
1
2008
336
0.520
Why?
Placebos
3
2006
178
0.510
Why?
United States
6
2007
2688
0.510
Why?
Risk Assessment
4
2007
884
0.490
Why?
Lidocaine
2
1999
74
0.470
Why?
Smoking
2
2007
399
0.470
Why?
Infection Control, Dental
1
2003
1
0.460
Why?
Laser Therapy
1
2003
62
0.450
Why?
Ultraviolet Therapy
2
1998
4
0.440
Why?
Adolescent
12
1993
4766
0.420
Why?
Burning Mouth Syndrome
1
2002
5
0.420
Why?
Skin Diseases
1
2003
120
0.410
Why?
Dental Materials
1
2002
26
0.410
Why?
Drug Hypersensitivity
1
2002
37
0.400
Why?
Questionnaires
4
2007
1004
0.400
Why?
Electric Stimulation Therapy
2
2011
29
0.390
Why?
Clinical Protocols
3
2007
106
0.380
Why?
Vidarabine
3
2003
26
0.370
Why?
Carotid Stenosis
3
2004
51
0.360
Why?
Adrenal Cortex Hormones
3
2008
96
0.350
Why?
Time Factors
7
1996
3182
0.350
Why?
Myeloablative Agonists
2
2006
6
0.350
Why?
Oral Ulcer
2
2008
8
0.340
Why?
Follow-Up Studies
5
2004
1855
0.330
Why?
Early Diagnosis
2
2007
29
0.330
Why?
Aged, 80 and over
4
2006
2529
0.330
Why?
Ischemic Attack, Transient
3
2002
41
0.320
Why?
Pain Measurement
2
2009
246
0.320
Why?
Statistics, Nonparametric
2
2007
262
0.310
Why?
Transplantation, Homologous
9
1997
276
0.310
Why?
Great Britain
2
2007
97
0.310
Why?
Thalidomide
1
1997
12
0.310
Why?
Sensation Disorders
1
1997
17
0.300
Why?
Mouth
1
1997
57
0.300
Why?
Hepatic Veno-Occlusive Disease
2
1993
3
0.290
Why?
Carotid Artery, Internal
3
2004
31
0.280
Why?
Leukemia, Myeloid, Acute
2
2007
177
0.280
Why?
Peripheral Nervous System Diseases
1
1997
104
0.280
Why?
Child
10
1997
4155
0.270
Why?
Anesthesia, Local
2
2002
20
0.260
Why?
Retrospective Studies
4
2004
2267
0.260
Why?
Cyclosporine
3
2003
64
0.250
Why?
Peripheral Blood Stem Cell Transplantation
2
2003
20
0.250
Why?
Quality of Life
2
2007
502
0.240
Why?
Israel
3
2002
38
0.240
Why?
Busulfan
4
2003
13
0.230
Why?
Glucocorticoids
3
2008
162
0.230
Why?
Case-Control Studies
2
1999
617
0.230
Why?
Chi-Square Distribution
2
2011
344
0.220
Why?
Cohort Studies
2
2006
969
0.220
Why?
Lingual Nerve
1
2012
8
0.210
Why?
Neutropenia
2
2009
67
0.210
Why?
Standard of Care
1
2012
4
0.210
Why?
Therapy, Computer-Assisted
1
2012
12
0.210
Why?
Dental Offices
2
2002
4
0.210
Why?
Bacterial Load
1
2011
2
0.210
Why?
Bacteria, Anaerobic
1
2011
7
0.210
Why?
Bacteria, Aerobic
1
2011
7
0.210
Why?
Staphylococcus
1
2011
11
0.210
Why?
Hematologic Neoplasms
3
2004
35
0.210
Why?
Viridans Streptococci
1
2011
3
0.210
Why?
Gram-Negative Bacteria
1
2011
21
0.200
Why?
Yeasts
1
2011
30
0.200
Why?
Tablets
1
2011
7
0.200
Why?
Streptococcus
1
2011
80
0.200
Why?
Safety
1
2011
101
0.200
Why?
Prosthesis-Related Infections
1
2011
11
0.200
Why?
Lichen Planus, Oral
1
2011
1
0.190
Why?
Stomatitis, Aphthous
1
2011
7
0.190
Why?
Bone Diseases, Metabolic
1
2011
20
0.190
Why?
Tetracyclines
1
2011
7
0.190
Why?
Sjogren's Syndrome
1
2011
16
0.190
Why?
Antibodies, Monoclonal
3
2006
711
0.190
Why?
Retinoids
1
2011
25
0.190
Why?
Drug Design
1
2010
42
0.190
Why?
Dental Pulp
1
2010
14
0.190
Why?
Radiography, Panoramic
3
2004
16
0.190
Why?
Epithelium
1
2011
228
0.180
Why?
Gaucher Disease
1
2010
6
0.180
Why?
Societies, Dental
1
2010
5
0.180
Why?
Drug Administration Schedule
1
2011
366
0.180
Why?
Neoplasms, Second Primary
2
2008
125
0.180
Why?
Herpes Simplex
1
2010
47
0.180
Why?
Mandibular Diseases
1
2009
16
0.180
Why?
Light
1
2010
159
0.180
Why?
Wound Healing
2
2008
206
0.180
Why?
Health Surveys
1
2010
215
0.170
Why?
Myelodysplastic Syndromes
2
2007
131
0.170
Why?
Virus Diseases
1
2010
83
0.170
Why?
Speech Disorders
2
2003
17
0.170
Why?
Clinical Trials as Topic
2
2006
671
0.170
Why?
Antihypertensive Agents
1
2010
79
0.170
Why?
National Institutes of Health (U.S.)
1
2009
63
0.170
Why?
American Hospital Association
1
2008
2
0.170
Why?
Lichenoid Eruptions
1
2008
1
0.170
Why?
Administration, Buccal
1
2008
3
0.170
Why?
Dentist's Practice Patterns
1
2008
6
0.170
Why?
Statistics as Topic
1
2009
185
0.170
Why?
Diabetes Mellitus
2
2002
169
0.170
Why?
Drug Therapy, Combination
2
2006
382
0.170
Why?
Dermatologic Agents
1
2009
24
0.160
Why?
International Normalized Ratio
1
2008
8
0.160
Why?
Oral Hemorrhage
1
2008
18
0.160
Why?
Lymphoma, B-Cell
1
2009
62
0.160
Why?
Carticaine
1
2008
1
0.160
Why?
Mucocele
1
2008
10
0.160
Why?
Blood Loss, Surgical
1
2008
44
0.160
Why?
Neutrophil Infiltration
1
2008
24
0.160
Why?
Ticlopidine
1
2008
6
0.160
Why?
Leukemia, Lymphoid
1
2008
63
0.160
Why?
Osteoporosis, Postmenopausal
1
2008
15
0.160
Why?
Logistic Models
1
2011
611
0.160
Why?
Guideline Adherence
1
2009
83
0.160
Why?
Erythroplasia
1
2007
1
0.160
Why?
Postoperative Hemorrhage
1
2008
19
0.160
Why?
Tooth Extraction
1
2008
34
0.160
Why?
Epinephrine
1
2008
141
0.160
Why?
Jaw, Edentulous, Partially
2
2004
17
0.150
Why?
Cytodiagnosis
1
2007
33
0.150
Why?
Confounding Factors (Epidemiology)
1
2008
61
0.150
Why?
Drug Combinations
1
2008
148
0.150
Why?
Aspirin
1
2008
59
0.150
Why?
World Health Organization
1
2008
42
0.150
Why?
Fatal Outcome
1
2008
104
0.150
Why?
Pain, Referred
1
2007
3
0.150
Why?
Herpesvirus 4, Human
1
2008
62
0.150
Why?
Infusions, Intravenous
1
2008
143
0.150
Why?
Observer Variation
1
2008
144
0.150
Why?
Trigeminal Neuralgia
1
2007
11
0.150
Why?
Lymphoma, Follicular
1
2008
54
0.150
Why?
Trigeminal Nerve
1
2007
18
0.150
Why?
Bone Marrow
1
2009
287
0.150
Why?
Tomography, X-Ray Computed
2
2003
759
0.150
Why?
Diagnosis, Differential
1
2010
874
0.150
Why?
Recombinant Fusion Proteins
1
2009
382
0.150
Why?
Immunosuppression
1
2007
64
0.140
Why?
Histamine H1 Antagonists, Non-Sedating
1
2006
2
0.140
Why?
Stress, Psychological
1
2010
285
0.140
Why?
Fanconi Anemia
1
2006
3
0.140
Why?
Necrosis
1
2006
103
0.140
Why?
Cardiovascular Diseases
1
2010
277
0.140
Why?
Gastrointestinal Diseases
1
2006
37
0.140
Why?
Societies, Medical
1
2007
138
0.140
Why?
Disease Models, Animal
2
2006
956
0.130
Why?
Random Allocation
1
2006
248
0.130
Why?
Analysis of Variance
1
2008
736
0.130
Why?
Haplotypes
1
2005
63
0.130
Why?
Health Knowledge, Attitudes, Practice
1
2008
267
0.130
Why?
Oxygen
1
2008
493
0.130
Why?
Longitudinal Studies
1
2006
395
0.120
Why?
Patient Satisfaction
1
2006
226
0.120
Why?
Postoperative Complications
1
2009
733
0.120
Why?
Bronchiolitis Obliterans
1
2003
5
0.120
Why?
Mediastinal Emphysema
1
2003
9
0.120
Why?
Glycoproteins
1
2005
201
0.120
Why?
Retreatment
1
2003
6
0.110
Why?
Ointments
1
2003
9
0.110
Why?
Animals
3
2006
16093
0.110
Why?
Nutritional Status
1
2003
44
0.110
Why?
Pain Management
1
2003
49
0.110
Why?
Peptides
1
2005
285
0.110
Why?
Electrocardiography
1
2008
773
0.110
Why?
Treatment Failure
1
2003
128
0.110
Why?
Carbon Dioxide
1
2003
205
0.110
Why?
Steroids
1
2003
54
0.110
Why?
Reproducibility of Results
1
2006
877
0.110
Why?
Tongue Diseases
1
2002
3
0.110
Why?
Health Services Needs and Demand
1
2003
103
0.100
Why?
Histamine Release
1
2002
5
0.100
Why?
Endocrine System Diseases
1
2002
13
0.100
Why?
Chest Pain
1
2002
17
0.100
Why?
Postmenopause
1
2002
43
0.100
Why?
Liability, Legal
1
2002
24
0.100
Why?
Respiratory Insufficiency
1
2002
58
0.100
Why?
Inflammation
1
2006
534
0.100
Why?
Syncope
1
2002
115
0.100
Why?
Prevalence
1
2002
562
0.090
Why?
Remission Induction
2
2009
161
0.080
Why?
Antibodies, Monoclonal, Humanized
2
2006
87
0.080
Why?
Fluorescent Antibody Technique
1
1999
283
0.080
Why?
Paresthesia
1
1997
18
0.080
Why?
Hypesthesia
1
1997
12
0.080
Why?
Mastectomy, Segmental
1
1997
25
0.080
Why?
Chemotherapy, Adjuvant
1
1997
88
0.070
Why?
Pulmonary Veno-Occlusive Disease
1
1997
3
0.070
Why?
Tretinoin
1
1997
103
0.070
Why?
Blood Platelet Disorders
1
1996
7
0.070
Why?
Enoxaparin
1
1996
8
0.070
Why?
Hematopoietic Stem Cell Mobilization
2
2003
14
0.070
Why?
Megakaryocytes
1
1996
67
0.070
Why?
Combined Modality Therapy
2
2005
486
0.070
Why?
Bone Neoplasms
1
1997
207
0.070
Why?
Anti-Bacterial Agents
2
2009
437
0.070
Why?
Fibrinolytic Agents
1
1996
61
0.070
Why?
Survival Analysis
2
2005
606
0.060
Why?
Calcinosis
2
2004
63
0.060
Why?
Graft Survival
2
2003
148
0.060
Why?
Secretory Rate
1
2012
42
0.050
Why?
Likelihood Functions
1
2012
52
0.050
Why?
Deglutition Disorders
1
2012
21
0.050
Why?
Selective Estrogen Receptor Modulators
1
2011
9
0.050
Why?
Calcium, Dietary
1
2011
20
0.050
Why?
Hormone Replacement Therapy
1
2011
15
0.050
Why?
Sleep Disorders
1
2012
69
0.050
Why?
Joint Prosthesis
1
2011
25
0.050
Why?
Intention to Treat Analysis
1
2011
9
0.050
Why?
Child, Preschool
2
2006
2660
0.050
Why?
Evidence-Based Dentistry
1
2010
7
0.050
Why?
Bacteremia
1
2011
38
0.050
Why?
Breast Neoplasms
1
1997
673
0.050
Why?
Parathyroid Hormone
1
2011
123
0.050
Why?
Bone Density
1
2011
111
0.050
Why?
Feasibility Studies
2
1996
202
0.050
Why?
Vitamin D
1
2011
71
0.050
Why?
RANK Ligand
1
2011
129
0.050
Why?
Pain, Intractable
1
2010
15
0.050
Why?
Radiation-Protective Agents
1
2010
41
0.040
Why?
Data Collection
1
2011
215
0.040
Why?
Prednisone
1
2010
165
0.040
Why?
Transplantation, Autologous
1
2009
144
0.040
Why?
Chimerism
1
2009
2
0.040
Why?
Histocompatibility
1
2009
13
0.040
Why?
Angiogenesis Inhibitors
1
2009
21
0.040
Why?
Surgical Procedures, Minimally Invasive
1
2009
30
0.040
Why?
Red-Cell Aplasia, Pure
1
2009
9
0.040
Why?
Alendronate
1
2009
26
0.040
Why?
Injections, Intravenous
1
2009
131
0.040
Why?
Dentists
1
2008
17
0.040
Why?
Terminology as Topic
1
2009
109
0.040
Why?
Antibodies, Monoclonal, Murine-Derived
1
2009
114
0.040
Why?
Immunoglobulins, Intravenous
1
2009
36
0.040
Why?
Imidazoles
1
2009
67
0.040
Why?
Radiation Injuries
1
2010
131
0.040
Why?
Administration, Oral
1
2009
308
0.040
Why?
Thrombocytopenia
1
2009
74
0.040
Why?
Dental Caries
1
2010
313
0.040
Why?
Recurrence
1
2009
691
0.040
Why?
Neoadjuvant Therapy
1
2007
32
0.040
Why?
Acute Disease
1
2009
586
0.040
Why?
Histocompatibility Testing
1
2006
37
0.040
Why?
Antilymphocyte Serum
1
2006
25
0.030
Why?
Drug Evaluation
1
2006
101
0.030
Why?
Antibodies, Neoplasm
1
2006
39
0.030
Why?
Curcumin
1
2006
23
0.030
Why?
Dietary Supplements
1
2006
44
0.030
Why?
Medical Oncology
1
2006
48
0.030
Why?
Primary Prevention
1
2006
58
0.030
Why?
Multivariate Analysis
1
2007
541
0.030
Why?
Attitude of Health Personnel
1
2008
289
0.030
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2006
92
0.030
Why?
Magnetic Resonance Imaging
1
2011
991
0.030
Why?
Ultrasonography, Doppler, Duplex
1
2004
22
0.030
Why?
Analgesics
1
2006
117
0.030
Why?
Radiotherapy
1
2006
198
0.030
Why?
Evidence-Based Medicine
1
2006
202
0.030
Why?
Endarterectomy, Carotid
1
2004
32
0.030
Why?
Survivors
1
2005
118
0.030
Why?
Antigens, CD
1
2005
244
0.030
Why?
Nasopharynx
1
2003
48
0.030
Why?
Hematopoiesis
1
2004
129
0.030
Why?
Adrenal Insufficiency
1
2002
5
0.030
Why?
Hyperventilation
1
2002
17
0.030
Why?
Hyperthyroidism
1
2002
24
0.030
Why?
Ethics, Dental
1
2002
4
0.030
Why?
Survival Rate
1
2004
618
0.030
Why?
Consciousness
1
2002
22
0.030
Why?
Central Nervous System Depressants
1
2002
10
0.030
Why?
Monitoring, Intraoperative
1
2002
29
0.030
Why?
Documentation
1
2002
31
0.030
Why?
Angina Pectoris
1
2002
49
0.030
Why?
Patient Selection
1
2003
212
0.030
Why?
Incidence
1
2004
685
0.030
Why?
Pulmonary Embolism
1
2002
57
0.020
Why?
Drug Interactions
1
2002
183
0.020
Why?
Hypoglycemia
1
2002
91
0.020
Why?
Respiration
1
2002
181
0.020
Why?
Norepinephrine
1
2002
256
0.020
Why?
Evaluation Studies as Topic
1
1997
245
0.020
Why?
Biological Availability
1
1996
40
0.020
Why?
Platelet Count
1
1996
50
0.020
Why?
Injections, Subcutaneous
1
1996
90
0.020
Why?
Myocardial Infarction
1
2002
660
0.020
Why?
Half-Life
1
1996
100
0.020
Why?
Blood Platelets
1
1996
277
0.010
Why?

Visualizations


Elad's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department